The estimated Net Worth of Jan Johannessen is at least $1.01 Milion dollars as of 9 February 2023. Mr. Johannessen owns over 1,732 units of Twist Bioscience Corp stock worth over $515,286 and over the last 21 years he sold TWST stock worth over $60,725. In addition, he makes $429,744 as Independent Director at Twist Bioscience Corp.
Jan has made over 6 trades of the Twist Bioscience Corp stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 1,732 units of TWST stock worth $45,829 on 9 February 2023.
The largest trade he's ever made was exercising 5,000 units of Twist Bioscience Corp stock on 16 February 2022 worth over $70,000. On average, Jan trades about 1,099 units every 32 days since 2003. As of 9 February 2023 he still owns at least 11,616 units of Twist Bioscience Corp stock.
You can see the complete history of Mr. Johannessen stock trades at the bottom of the page.
Jan Johannessen serves as Independent Director of the Company. Mr. Johannessen currently serves as an advisor to iGlobe Partners, a venture capital company. Mr. Johannessen served as Chief Operating Officer and Secretary at Conexant Systems, LLC, a semiconductor company, from May 2013 to August 2017 and also served as its Chief Financial Officer from May 2013 to May 2016 and as its Chief Executive Officer from May 2016 to August 2017. Mr. Johannessen served as Chief Financial Officer and Secretary at REC Silicon ASA, a company listed on the Oslo stock exchange from August 2008 to May 2013. He served as Interim Chief Executive Officer and President at Lattice Semiconductor Corporation, a publicly traded company, from May 2008 to August 2008 and as Chief Financial Officer and Secretary at Lattice Semiconductor Corporation from December 2003 to May 2008. Mr. Johannessen holds a B.S. in Business from the University of Houston, and a MBA in International Business from Arizona State University. Our board of directors believes that Mr. Johannessen brings extensive executive experience in the technology industry and financial and accounting expertise, which qualifies him to serve as one of our directors.
As the Independent Director of Twist Bioscience Corp, the total compensation of Jan Johannessen at Twist Bioscience Corp is $429,744. There are 9 executives at Twist Bioscience Corp getting paid more, with Emily Leproust having the highest compensation of $8,126,160.
Jan Johannessen is 63, he's been the Independent Director of Twist Bioscience Corp since 2018. There are 4 older and 18 younger executives at Twist Bioscience Corp. The oldest executive at Twist Bioscience Corp is Dr. William Charles Banyai Ph.D., 66, who is the Sr. VP of Advanced Devel., GM of Data Storage & Director.
Jan's mailing address filed with the SEC is C/O TWIST BIOSCIENCE CORPORATION, 681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA, 94080.
Over the last 6 years, insiders at Twist Bioscience Corp have traded over $141,837,821 worth of Twist Bioscience Corp stock and bought 168,550 units worth $2,482,088 . The most active insiders traders include Fred B Craves, Keith Crandell a Emily M. Leproust. On average, Twist Bioscience Corp executives and independent directors trade stock every 8 days with the average trade being worth of $465,824. The most recent stock trade was executed by Dennis Cho on 6 September 2024, trading 275 units of TWST stock currently worth $10,769.
at twist bioscience, our expertise is synthetic dna. we have developed a proprietary semiconductor-based synthetic dna manufacturing process featuring a 10,000-well silicon platform capable of producing synthetic biology tools, such as oligonucleotides, genes, pathways, chassis and genomes. by synthesizing dna on silicon instead of on traditional 96-well plastic plates, our platform overcomes the current inefficiencies of synthetic dna production, and enables cost-effective, rapid, high-quality and high throughput synthetic gene production. the twist bioscience platform has the potential to greatly accelerate the development of personalized medicine, sustainable chemical production, improved agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. for more information, please visit www.twistbioscience.com .
Twist Bioscience Corp executives and other stock owners filed with the SEC include: